{"rows":[{"id":5933,"title":"Psilocybin and ayahuasca in treatment-resistant depression: clinical evidence, methodological constraints and ethical challenges: a narrative review","authors":"Civardi S, Besana F, Durbano F, Toscano M, Raffone F, Dell’Osso B, Olivola M.","journal":"Frontiers in psychiatry","publication_date":"2026-09-30","publication_year":2026,"doi":"10.3389/fpsyt.2026.1858319","pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC13621360","substance_tags":"psilocybin","topic_tags":"Depression,Review Article,Treatment-Resistant Depression","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-16 01:20:15","last_checked":"2026-10-03 01:20:25","bibtex":null,"source_record_id":"DOI:10.3389/fpsyt.2026.1858319","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://europepmc.org/article/PMC/PMC13621360","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.3389/fpsyt.2026.1858319","source_url":"https://europepmc.org/article/PMC/PMC13621360","doi":"10.3389/fpsyt.2026.1858319","pmid":"","publication_date":"2026-09-30","importer_version":"2.1.3","text_redistributed":false}},{"id":5903,"title":"Surrender, disidentification, and reappraisal: a qualitative comparison of psilocybin responders and non-responders in treatment-resistant OCD","authors":"Agin-Liebes G, Shnayder S, Fram G, Swift T, Ching T, Jankovsky A, Hokanson J, Pittenger C, Kelmendi B.","journal":"Frontiers in psychiatry","publication_date":"2026-09-16","publication_year":2026,"doi":"10.3389/fpsyt.2026.1791689","pubmed_id":null,"openalex_id":"https://openalex.org/W7204873279","source_url":"https://europepmc.org/article/PMC/PMC13576466","substance_tags":"psilocybin","topic_tags":"OCD","study_type":"Qualitative Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-03 01:20:15","last_checked":"2026-09-17 01:20:18","bibtex":null,"source_record_id":"DOI:10.3389/fpsyt.2026.1791689","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://europepmc.org/article/PMC/PMC13576466","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.3389/fpsyt.2026.1791689","source_url":"https://europepmc.org/article/PMC/PMC13576466","doi":"10.3389/fpsyt.2026.1791689","pmid":"","publication_date":"2026-09-16","importer_version":"2.1.3","text_redistributed":false}},{"id":5727,"title":"Sex-dependent effects of psychedelics: review of evidence from rodent models.","authors":"Marecki R, Zaniewska W, Hamed A, Waszkiewicz N, Baker JJ, Łukasiewicz K","journal":"Frontiers in psychiatry","publication_date":"2026-01-01","publication_year":2026,"doi":"10.3389/fpsyt.2026.1824073","pubmed_id":"42528876","openalex_id":"https://openalex.org/W7168359165","source_url":"https://pubmed.ncbi.nlm.nih.gov/42528876/","substance_tags":"psilocybin,psilocin","topic_tags":"Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Microdosing,Review Article","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-17 01:20:14","last_checked":"2026-08-09 08:27:45","bibtex":null,"source_record_id":"PMID:42528876","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42528876/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42528876","source_url":"https://pubmed.ncbi.nlm.nih.gov/42528876/","doi":"10.3389/fpsyt.2026.1824073","pmid":"42528876","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2447,"title":"The \"Endless Trip\" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.","authors":"Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F","journal":"Frontiers in psychiatry","publication_date":"2017-01-01","publication_year":2017,"doi":"10.3389/fpsyt.2017.00240","pubmed_id":"29209235","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/29209235/","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Systematic Review,Review Article,Safety","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:26","bibtex":null,"source_record_id":"PMID:29209235","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/29209235/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:29209235","source_url":"https://pubmed.ncbi.nlm.nih.gov/29209235/","doi":"10.3389/fpsyt.2017.00240","pmid":"29209235","publication_date":"2017-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2398,"title":"Psilocybin and Mental Health-Don't Lose Control.","authors":"Barnby JM, Mehta MA","journal":"Frontiers in psychiatry","publication_date":"2018-01-01","publication_year":2018,"doi":"10.3389/fpsyt.2018.00293","pubmed_id":"30018574","openalex_id":"https://openalex.org/W2807830955","source_url":"https://pubmed.ncbi.nlm.nih.gov/30018574/","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:30018574","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/30018574/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:30018574","source_url":"https://pubmed.ncbi.nlm.nih.gov/30018574/","doi":"10.3389/fpsyt.2018.00293","pmid":"30018574","publication_date":"2018-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2329,"title":"Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.","authors":"Hutten NRPW, Mason NL, Dolder PC, Kuypers KPC","journal":"Frontiers in psychiatry","publication_date":"2019-01-01","publication_year":2019,"doi":"10.3389/fpsyt.2019.00672","pubmed_id":"31572246","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/31572246/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Microdosing,Clinical Trial,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:31572246","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/31572246/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:31572246","source_url":"https://pubmed.ncbi.nlm.nih.gov/31572246/","doi":"10.3389/fpsyt.2019.00672","pmid":"31572246","publication_date":"2019-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2303,"title":"Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.","authors":"Garcia-Romeu A, Davis AK, Erowid E, Erowid F, Griffiths RR, Johnson MW","journal":"Frontiers in psychiatry","publication_date":"2019-01-01","publication_year":2019,"doi":"10.3389/fpsyt.2019.00955","pubmed_id":"32038317","openalex_id":"https://openalex.org/W3001327571","source_url":"https://pubmed.ncbi.nlm.nih.gov/32038317/","substance_tags":"psilocybin","topic_tags":"Addiction,Receptor Pharmacology,Mystical Experience,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32038317","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32038317/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32038317","source_url":"https://pubmed.ncbi.nlm.nih.gov/32038317/","doi":"10.3389/fpsyt.2019.00955","pmid":"32038317","publication_date":"2019-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2297,"title":"Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.","authors":"Sexton JD, Nichols CD, Hendricks PS","journal":"Frontiers in psychiatry","publication_date":"2019-01-01","publication_year":2019,"doi":"10.3389/fpsyt.2019.00896","pubmed_id":"32116806","openalex_id":"https://openalex.org/W3006069447","source_url":"https://pubmed.ncbi.nlm.nih.gov/32116806/","substance_tags":"psilocybin","topic_tags":"Pharmacology,Observational Study,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32116806","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32116806/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32116806","source_url":"https://pubmed.ncbi.nlm.nih.gov/32116806/","doi":"10.3389/fpsyt.2019.00896","pmid":"32116806","publication_date":"2019-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2294,"title":"Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance.","authors":"Wolff M, Evens R, Mertens LJ, Koslowski M, Betzler F, Gründer G, Jungaberle H","journal":"Frontiers in psychiatry","publication_date":"2020-01-01","publication_year":2020,"doi":"10.3389/fpsyt.2020.00005","pubmed_id":"32153433","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/32153433/","substance_tags":"psilocybin","topic_tags":"Mechanism of Action","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32153433","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32153433/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32153433","source_url":"https://pubmed.ncbi.nlm.nih.gov/32153433/","doi":"10.3389/fpsyt.2020.00005","pmid":"32153433","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2288,"title":"Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.","authors":"Heuschkel K, Kuypers KPC","journal":"Frontiers in psychiatry","publication_date":"2020-01-01","publication_year":2020,"doi":"10.3389/fpsyt.2020.00224","pubmed_id":"32296353","openalex_id":"https://openalex.org/W3014277121","source_url":"https://pubmed.ncbi.nlm.nih.gov/32296353/","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Biomarkers,Review Article,Immune Function","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32296353","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32296353/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32296353","source_url":"https://pubmed.ncbi.nlm.nih.gov/32296353/","doi":"10.3389/fpsyt.2020.00224","pmid":"32296353","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2273,"title":"Editorial: Hallucinogens and Entactogens: Establishing a New Class of Drugs?","authors":"Müller F, Johnson MW, Borgwardt S","journal":"Frontiers in psychiatry","publication_date":"2020-01-01","publication_year":2020,"doi":"10.3389/fpsyt.2020.00497","pubmed_id":"32547435","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/32547435/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32547435","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32547435","source_url":"https://pubmed.ncbi.nlm.nih.gov/32547435/","doi":"10.3389/fpsyt.2020.00497","pmid":"32547435","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2232,"title":"Commentary: Psychedelic Psychiatry's Brave New World.","authors":"Nobile B, Olié E, Courtet P","journal":"Frontiers in psychiatry","publication_date":"2020-01-01","publication_year":2020,"doi":"10.3389/fpsyt.2020.594077","pubmed_id":"33324259","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/33324259/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:33324259","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33324259","source_url":"https://pubmed.ncbi.nlm.nih.gov/33324259/","doi":"10.3389/fpsyt.2020.594077","pmid":"33324259","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2222,"title":"Self-Reported Illicit Drug Use Among Norwegian University and College Students. Associations With Age, Gender, and Geography.","authors":"Heradstveit O, Skogen JC, Edland-Gryt M, Hesse M, Vallentin-Holbech L, Lønning KJ, Sivertsen B","journal":"Frontiers in psychiatry","publication_date":"2020-01-01","publication_year":2020,"doi":"10.3389/fpsyt.2020.543507","pubmed_id":"33362594","openalex_id":"https://openalex.org/W3112932345","source_url":"https://pubmed.ncbi.nlm.nih.gov/33362594/","substance_tags":"psilocybin","topic_tags":"Addiction,Wellbeing,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:33362594","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33362594/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33362594","source_url":"https://pubmed.ncbi.nlm.nih.gov/33362594/","doi":"10.3389/fpsyt.2020.543507","pmid":"33362594","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2198,"title":"Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.","authors":"Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA, Reinholdt F, Richards BD, Gasser P, Malievskaia E","journal":"Frontiers in psychiatry","publication_date":"2021-01-01","publication_year":2021,"doi":"10.3389/fpsyt.2021.586682","pubmed_id":"33643087","openalex_id":"https://openalex.org/W3127909847","source_url":"https://pubmed.ncbi.nlm.nih.gov/33643087/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:33643087","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33643087/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33643087","source_url":"https://pubmed.ncbi.nlm.nih.gov/33643087/","doi":"10.3389/fpsyt.2021.586682","pmid":"33643087","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2164,"title":"Psilocybin: From Serendipity to Credibility?","authors":"Rucker JJ, Young AH","journal":"Frontiers in psychiatry","publication_date":"2021-01-01","publication_year":2021,"doi":"10.3389/fpsyt.2021.659044","pubmed_id":"33967860","openalex_id":"https://openalex.org/W3154999065","source_url":"https://pubmed.ncbi.nlm.nih.gov/33967860/","substance_tags":"psilocybin","topic_tags":"Depression,Aging,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:33967860","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33967860/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33967860","source_url":"https://pubmed.ncbi.nlm.nih.gov/33967860/","doi":"10.3389/fpsyt.2021.659044","pmid":"33967860","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2150,"title":"Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.","authors":"Révész D, Ona G, Rossi GN, Rocha JM, Dos Santos RG, Hallak JEC, Alcázar-Córcoles MÁ, Bouso JC","journal":"Frontiers in psychiatry","publication_date":"2021-01-01","publication_year":2021,"doi":"10.3389/fpsyt.2021.687546","pubmed_id":"34220590","openalex_id":"https://openalex.org/W3167904654","source_url":"https://pubmed.ncbi.nlm.nih.gov/34220590/","substance_tags":"psilocybin","topic_tags":"Personality Change,Spirituality,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:34220590","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34220590/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34220590","source_url":"https://pubmed.ncbi.nlm.nih.gov/34220590/","doi":"10.3389/fpsyt.2021.687546","pmid":"34220590","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2149,"title":"Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.","authors":"Mans K, Kettner H, Erritzoe D, Haijen ECHM, Kaelen M, Carhart-Harris RL","journal":"Frontiers in psychiatry","publication_date":"2021-01-01","publication_year":2021,"doi":"10.3389/fpsyt.2021.647909","pubmed_id":"34267683","openalex_id":"https://openalex.org/W3174895070","source_url":"https://pubmed.ncbi.nlm.nih.gov/34267683/","substance_tags":"psilocybin","topic_tags":"Wellbeing,Spirituality,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:34267683","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34267683/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34267683","source_url":"https://pubmed.ncbi.nlm.nih.gov/34267683/","doi":"10.3389/fpsyt.2021.647909","pmid":"34267683","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2142,"title":"Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?","authors":"Kočárová R, Horáček J, Carhart-Harris R","journal":"Frontiers in psychiatry","publication_date":"2021-01-01","publication_year":2021,"doi":"10.3389/fpsyt.2021.661233","pubmed_id":"34349678","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/34349678/","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Biomarkers,Wellbeing,Resilience,Psychological Flexibility","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:34349678","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34349678/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34349678","source_url":"https://pubmed.ncbi.nlm.nih.gov/34349678/","doi":"10.3389/fpsyt.2021.661233","pmid":"34349678","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2134,"title":"Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.","authors":"Mendes Rocha J, Rossi GN, Osório FL, Bouso Saiz JC, Silveira GO, Yonamine M, Crevelin EJ, Queiroz ME, Cecílio Hallak JE, Dos Santos RG","journal":"Frontiers in psychiatry","publication_date":"2021-01-01","publication_year":2021,"doi":"10.3389/fpsyt.2021.688439","pubmed_id":"34421675","openalex_id":"https://openalex.org/W3191241244","source_url":"https://pubmed.ncbi.nlm.nih.gov/34421675/","substance_tags":"psilocybin","topic_tags":"Personality Change,Healthy Volunteers","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:34421675","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34421675/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34421675","source_url":"https://pubmed.ncbi.nlm.nih.gov/34421675/","doi":"10.3389/fpsyt.2021.688439","pmid":"34421675","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2133,"title":"Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy.","authors":"Eleftheriou ME, Thomas E","journal":"Frontiers in psychiatry","publication_date":"2021-01-01","publication_year":2021,"doi":"10.3389/fpsyt.2021.707057","pubmed_id":"34456763","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/34456763/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Wellbeing,Healthy Volunteers","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:34456763","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34456763/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34456763","source_url":"https://pubmed.ncbi.nlm.nih.gov/34456763/","doi":"10.3389/fpsyt.2021.707057","pmid":"34456763","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":92,"page":1,"per_page":20,"pages":5,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Frontiers in psychiatry","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}